Tricuspid valve endocarditis in association with Truperella bernerdiae and Fusobacterium species bacteraemia in an injecting drug user: a case report

Pathology ◽  
2017 ◽  
Vol 49 ◽  
pp. S116
Author(s):  
Julia Howard ◽  
Philip Drennan ◽  
Sarah Metcalf
Keyword(s):  
Case Report ◽  
Drug User ◽  
Tricuspid Valve ◽  
Fusobacterium Species ◽  
Injecting Drug User ◽  
Tricuspid Valve Endocarditis

scholarly journals Tricuspid valve endocarditis in pregnancy: a case report and review of the literature

2021 ◽  
Vol 11 (1) ◽  
pp. 99-102
Author(s):  
Robert Libera ◽  
Kyle Macaulay ◽  
Anthony A. Donato ◽  
Jared Green ◽  
Christine McCarty
Keyword(s):  
Case Report ◽  
Tricuspid Valve ◽  
Review Of The Literature ◽  
Tricuspid Valve Endocarditis ◽  
In Pregnancy

scholarly journals AngioVac System Used for Vegetation Debulking in a Patient with Tricuspid Valve Endocarditis: A Case Report and Review of the Literature

2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Hossam Abubakar ◽  
Ahmed Rashed ◽  
Ahmed Subahi ◽  
Ahmed S. Yassin ◽  
Mohamed Shokr ◽  
...  
Keyword(s):  
Case Report ◽  
Tricuspid Valve ◽  
The Novel ◽  
Review Of The Literature ◽  
Novel Device ◽  
Heart Chamber ◽  
Improved Outcomes ◽  
Percutaneous Removal ◽  
Few Data ◽  
Tricuspid Valve Endocarditis

AngioVac is a vacuum-based device approved in 2014 for percutaneous removal of undesirable materials from the intravascular system. Although numerous reports exist with regard to the use of the AngioVac device in aspiration of iliocaval, pulmonary, upper extremity, and right-sided heart chamber thrombi, very few data are present demonstrating its use in treatment of right-sided endocarditis. In this case report, we describe the novel device used in debulking a large right-sided tricuspid valve vegetation reducing the occurrence of septic embolisation and enhancing the efficacy of antibiotics in clearance of bloodstream infection. Further research is needed in larger RSIE patient populations to confirm the benefits and the potential of improved outcomes associated with the AngioVac device as well as identify its potential complications.

scholarly journals Lost without Occam's razor: Escherichia coli tricuspid valve endocarditis in a non-intravenous drug user

2010 ◽  
Vol 2010 (aug06 1) ◽  
pp. bcr0220102769-bcr0220102769 ◽  
Author(s):  
J.-a. Foley ◽  
D. Augustine ◽  
R. Bond ◽  
K. Boyce ◽  
D. MacIver
Keyword(s):  
Escherichia Coli ◽  
Drug User ◽  
Tricuspid Valve ◽  
Intravenous Drug User ◽  
Intravenous Drug ◽  
Occam’S Razor ◽  
Tricuspid Valve Endocarditis ◽  
Occam's Razor

scholarly journals Tricuspid valve endocarditis complicated by Mobitz type II heart block – a case report and literature review

2015 ◽  
Vol 5 (6) ◽  
pp. 29689
Author(s):  
Chidozie Charles Agu ◽  
Divya Salhan ◽  
Ahmed Bakhit ◽  
Hiba Basheer ◽  
Md Basunia ◽  
...  
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Tricuspid Valve ◽  
Heart Block ◽  
Type Ii ◽  
Mobitz Type ◽  
Tricuspid Valve Endocarditis

scholarly journals Massive haemoptysis in an intravenous drug user with infective tricuspid valve endocarditis

2010 ◽  
Vol 2010 (aug23 1) ◽  
pp. bcr1020092404-bcr1020092404 ◽  
Author(s):  
K. A. L. Muller ◽  
C. S. Zurn ◽  
H. Patrik ◽  
M. Heuschmid ◽  
J. Hetzel ◽  
...  
Keyword(s):  
Drug User ◽  
Tricuspid Valve ◽  
Intravenous Drug User ◽  
Intravenous Drug ◽  
Massive Haemoptysis ◽  
Tricuspid Valve Endocarditis
Sign in / Sign up

Export Citation Format

Share Document